Maiden Pharma had licence to export medicines, says Centre | Latest News India - Hindustan Times
close_game
close_game

Maiden Pharma had licence to export medicines, says Centre

By, New Delhi
Oct 07, 2022 02:09 AM IST

WHO has a Prequalification of Medicines Programme (PQP) to ensure medicines supplied by procurement agencies meet acceptable standards of quality, safety and efficacy. Many countries use WHO prequalification as a criterion to directly import drugs.

Indian pharmaceutical company Maiden Pharmaceuticals Ltd, whose cough syrups were found to be contaminated, likely killing 66 children in The Gambia, had requisite permission to export the drugs from a state licensing authority in India, the Union ministry of health and family welfare said on Thursday.

Since the manufacturing unit is in Sonepat, Haryana, the licence was issued by the local regulator there. (PTI)
Since the manufacturing unit is in Sonepat, Haryana, the licence was issued by the local regulator there. (PTI)

“The State Drug Controller had given licenses to the said Company only for export of these four drugs namely Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup and MaGrip n Cold Syrup. Further all these 04 drugs manufactured only for exports by M/s. Maiden Pharmaceuticals Limited are not licensed for manufacture and sale in India. In effect, none of these four drugs of M/s. Maiden Pharmaceuticals is sold domestically in India,” the ministry said.

Hindustan Times - your fastest source for breaking news! Read now.

Since the manufacturing unit is in Sonepat, Haryana, the licence was issued by the local regulator there.

According to people familiar with the matter in the government, the regulations governing India’s drugs licensing practice are strict and adhere to World Health Organization norms.

“Not just the relevant data but also manufacturing practices are carefully inspected when licenses are issued for sale and distribution, including drugs that are meant for export purposes. India’s regulations are on par with global standards, which incudes WHO norms,” said a senior official in the regulatory division, asking not to be named.

WHO has a Prequalification of Medicines Programme (PQP) to ensure medicines supplied by procurement agencies meet acceptable standards of quality, safety and efficacy. Many countries use WHO prequalification as a criterion to directly import drugs.

PQP also prequalifies active pharmaceutical ingredients and quality control laboratories.

The manufacturer provides a comprehensive set of data about the quality, safety and efficacy of the product submitted for evaluation. This includes data on the purity of all ingredients used in manufacture; data on the finished pharmaceutical product (such as information about stability); and results of bioequivalence tests (clinical trials conducted in healthy volunteers), unless waived.

A team of assessors evaluates all the data presented, and a separate team of inspectors verifies the manufacturing sites for the finished pharmaceutical product, and its active pharmaceutical product and its active pharmaceutical ingredient comply with WHO good manufacturing practice.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Mukhtar Ansari Death News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
  • ABOUT THE AUTHOR
    author-default-90x90

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On